Provider of sensor to monitor heart arrhythmia and vital signs. It develops medical sensors that can continuously monitor and diagnose patients non-invasively, over the wrist. It can be used to monitor cardiac arrest, atrial fibrillation, and vital signs. Founded in 2012, headquartered in Caesarea, Israel. The company has raised $14.5M in funding at the series b stage. The team comprises 10+ (Mar 1, 2026) employees. The company operates in the Cardiac and Vascular Disorders sector with additional focus on Disease Self Management and Healthcare IT. Its business model centers on Cardiac. Founded in 2012, headquartered in Caesarea, Israel. The company has raised $14.5M at the Series B stage. Backed by investors including EIC Fund, Europa, Merchavia Holdings and Investments, Cashline Investment Holding.
CardiacSense
Series BProvider of sensor to monitor heart arrhythmia and vital signs. It develops medical sensors that can continuously monitor and diagnose patients non-invasively, over the wrist. It can be used to monitor cardiac arrest, atrial fibrillation, and vital signs. Founded in 2012, headquartered in Caesarea, Israel. The company has raised $14.5M in funding at the series b stage. The team comprises 10+ (Mar 1, 2026) employees.…
About
Business model
Wearable Technology > Health and Wellness Devices > Cardiac,
Disease Self Management > Cardiac and Vascular Disorders > Monitoring > Heart Health > Device > Wearable,
Healthcare IT > Value Based Care > Remote Monitoring > Hardware > Cardiology > Wearable,
Cardiac and Vascular Disorders > Medical Devices > Screening Devices > Cardiac Diagnostic > Electrodiagnostic Testing (ECG) > Home Based
Institutional investors
Latest coverage
📰 Latest funding news — recent raises and deal signals across the ecosystem.
Investor directory
🗂️ Browse all funds in our directory — active VCs and growth investors by stage and sector.